课题基金 / 基金详情

DISCOVERY AND EXPRESSION OF NEW ANTICHOLINERGIC TOXINS

DISCOVERY AND EXPRESSION OF NEW ANTICHOLINERGIC TOXINS
新抗胆碱能毒素的发现和表达
批准号：
2517013
负责人：
Lincoln T. Potter
金额：
$19.55万
依托单位：
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
1995
资助国家：
美国
项目状态：
已结题
起止时间：
1995-09-01 至 1999-08-31
来源：
https://reporter.nih.gov/project-details/2517013
关键词：
anticholinergic agent complementary DNA molecular cloning muscarinic receptor neurotoxins protein folding receptor binding recombinant DNA recombinant proteins reptile poison snakes

项目摘要

项目成果

Lincoln T. Potter的其他基金

相似基金

相关文献

中文摘要
翻译
描述：（改编自申请人摘要）研究者有
英文摘要
DESCRIPTION: (adapted from Applicant's Abstract) The investigators have shown that the venom of the Eastern green mamba from Africa, Dendroaspis angusticeps, is an excellent source for toxins that distinguish the m1 and m4 subtypes of muscarinic receptors, and have preliminary evidence for the presence of toxins specific for m2 receptors. The anti-muscarinic and toxins are present only in trace amounts. They therefore hypothesize that the toxins of most interest can be best identified by a combination of protein purification and recombinant DNA approaches, and obtained most easily in useful quantities by expression of the corresponding cDNA clones.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Site-directed mutagenesis of m1-toxin1: two amino acids responsible for stable toxin binding to M(1) muscarinic receptors.
DOI： --
发表时间： 2001-10
期刊： Molecular pharmacology
影响因子： 3.6
作者： [J. Krajewski;I. Dickerson;L. Potter]
通讯作者： J. Krajewski;I. Dickerson;L. Potter
DISCOVERY AND EXPRESSION OF NEW ANTICHOLINERGIC TOXINS
DISCOVERY AND EXPRESSION OF NEW ANTICHOLINERGIC TOXINS
CHOLINERGIC REPLACEMENT THERAPY
CHOLINERGIC REPLACEMENT THERAPY
海外基金